Interferons, which induce several intracellular antiviral proteins, al
so induce an extracellular soluble protein that inhibits vesicular sto
matitis virus (VSV) infection. This 28-kilodalton soluble protein was
purified to homogeneity and identified by protein sequencing as the li
gand-binding domain of the human 160-kilodalton low density lipoprotei
n receptor (LDLR). The existence of an antiviral soluble LDLR was conf
irmed by immunoaffinity chromatography with monoclonal antibody to LDL
R. This soluble receptor mediates most of the interferon-triggered ant
iviral activity against VSV, apparently by interfering with virus asse
mbly or budding, and not by inhibiting virus attachment to cells.